Prestige Consumer Healthcare Inc.
PBHNYSEHealthcare● Active
$48.99
+$1.27(+2.65%)
Market Cap$2.3B
P/E Ratio—
52W High$87.12
52W Low$42.62
Prestige Consumer Healthcare Inc. (PBH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PBH · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$1.23
Est. $1.39 · -11.5%
Revenue
$0.28B
Est. $0.29B · -4.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
PBH reports quarterly as a NYSE-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.89 | — | — | — | $0.25B | — |
| ▼ Q2 FY2026 | May 13, 2026 | $1.39 | $1.23 | -11.5% | $0.28B | $0.29B | -4.1% |
| ▼ Q1 FY2026 | Feb 5, 2026 | $1.16 | $1.14 | -1.7% | $0.28B | $0.28B | +0.4% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.97 | $1.07 | +10.3% | $0.27B | $0.29B | -6.8% |
| ▼ Q3 FY2025 | Aug 7, 2025 | $1.01 | $0.95 | -5.9% | $0.25B | $0.27B | -9.3% |
| ▲ Q2 FY2025 | May 8, 2025 | $1.30 | $1.32 | +1.5% | $0.30B | $0.27B | +9.7% |
| ▲ Q1 FY2025 | Feb 6, 2025 | $1.16 | $1.22 | +5.2% | $0.29B | $0.29B | +0.2% |
| — Q4 FY2024 | Nov 7, 2024 | $1.08 | $1.09 | +0.9% | $0.28B | $0.28B | +0.5% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.89
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
$1.23
EPS Est.
$1.39
EPS Surpr.
-11.5%
Revenue
$0.28B
Q1 FY2026
Feb 5, 2026Miss
EPS Actual
$1.14
EPS Est.
$1.16
EPS Surpr.
-1.7%
Revenue
$0.28B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$1.07
EPS Est.
$0.97
EPS Surpr.
+10.3%
Revenue
$0.27B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
$0.95
EPS Est.
$1.01
EPS Surpr.
-5.9%
Revenue
$0.25B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$1.32
EPS Est.
$1.30
EPS Surpr.
+1.5%
Revenue
$0.30B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$1.22
EPS Est.
$1.16
EPS Surpr.
+5.2%
Revenue
$0.29B
Q4 FY2024
Nov 7, 2024
EPS Actual
$1.09
EPS Est.
$1.08
EPS Surpr.
+0.9%
Revenue
$0.28B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $1.40 | $1.46 | $1.53 | 1 |
| Q4 FY2027 | $1.29 | $1.35 | $1.41 | 1 |
| Q3 FY2027 | $1.15 | $1.21 | $1.26 | 1 |
| Q2 FY2027 | $0.96 | $1.01 | $1.05 | 1 |
| Q1 FY2027 | $1.26 | $1.32 | $1.38 | 1 |
| Q4 FY2026 | $1.17 | $1.22 | $1.28 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2027 | $0.3B | $0.3B | $0.4B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -11.5% | $50.41 | $51.81 | +2.78% |
| ▼ Q1 FY2026 | Feb 5, 2026 | -1.7% | $67.03 | $65.55 | -2.21% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +10.3% | $59.83 | $61.36 | +2.56% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -5.9% | $75.16 | $67.61 | -10.05% |
| ▲ Q2 FY2025 | May 8, 2025 | +1.5% | $81.41 | $87.04 | +6.92% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +5.2% | $76.10 | $87.35 | +14.78% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +0.9% | $77.64 | $80.09 | +3.16% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +4.7% | $67.89 | $66.84 | -1.55% |
Q2 FY2026+2.78%
Report Date
May 13, 2026
EPS Beat/Miss
-11.5%
Price Before
$50.41
Price After
$51.81
Q1 FY2026-2.21%
Report Date
Feb 5, 2026
EPS Beat/Miss
-1.7%
Price Before
$67.03
Price After
$65.55
Q4 FY2025+2.56%
Report Date
Nov 6, 2025
EPS Beat/Miss
+10.3%
Price Before
$59.83
Price After
$61.36
Q3 FY2025-10.05%
Report Date
Aug 7, 2025
EPS Beat/Miss
-5.9%
Price Before
$75.16
Price After
$67.61
Q2 FY2025+6.92%
Report Date
May 8, 2025
EPS Beat/Miss
+1.5%
Price Before
$81.41
Price After
$87.04
Q1 FY2025+14.78%
Report Date
Feb 6, 2025
EPS Beat/Miss
+5.2%
Price Before
$76.10
Price After
$87.35
Q4 FY2024+3.16%
Report Date
Nov 7, 2024
EPS Beat/Miss
+0.9%
Price Before
$77.64
Price After
$80.09
Q3 FY2024-1.55%
Report Date
Aug 8, 2024
EPS Beat/Miss
+4.7%
Price Before
$67.89
Price After
$66.84
Avg Beat Reaction+5.17%
Avg Miss Reaction-3.16%
Beat Rate5 / 8 quarters
Largest Move+14.78% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PBH ends December
Prestige Consumer Healthcare Inc. (PBH) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $1.23 — missing the analyst consensus of $1.39 by -11.5%. The next PBH earnings date is expected around September 1, 2026.
Each quarter, investors track PBH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PBH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PBH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PBH earnings · 5 questionsPrestige Consumer Healthcare Inc.'s next earnings report is expected around September 1, 2026. PBH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PBH historically reports after market close (AMC).
PBH earnings datewhen is PBH earningsPBH next earnings datewhen does PBH report earningsPBH earnings calendar
▸ Source: FMP · Prestige Consumer Healthcare Inc. SEC filings · US GAAP · Prestige Consumer Healthcare Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026